CECOG Academy

www.cecog.org

 

Videos
30:18

CECOG Academy

CPIs in Cancer Treatment: Key Components of the Immune Defence, Immune Recognition, Surveillance / Evasion Mechanisms, IO Types, Combo Strategies to Avoid Resistance Development

FEATURING Walter Berger
  • 2 views
  • April 13, 2021
30:18

CECOG Academy

Rationale for Immune CPIs in Cancer Treatment: Key Concepts of the Immune Defence, IO Types, Combo Strategies to Avoid Resistance, Neoadjuvant vs. Adjuvant.

FEATURING Walter Berger
  • 3 views
  • March 29, 2021
20:56

CECOG Academy

Skeletal Health in Breast Cancer: Brief Comparison of BTAs in Advanced BC, Issues of Bone Health in EBC (Morbidity & Mortality of Fractures, "Anti-resorptive" Treatments, Rebound After D-mab)

FEATURING Peter Dubsky
  • 20 views
  • March 29, 2021
36:33

CECOG Academy

Neoadjuvant Treatment of NSCLC With Immune CPIs: Biological Understanding of the Disease, CPIs + Chemo Combinations

FEATURING Christoph Zielinski
  • 195 views
  • March 24, 2021
  • 1
05:03

CECOG Academy

Immune CPIs in ES-SCLC: How Effective Are Durvalumab, Atezolizumab & Pembrolizumab?

FEATURING Wolfgang Kostler
  • 111 views
  • March 24, 2021
06:52

CECOG Academy

Immune CPIs in NSCLC: Durvalumab After cCRT for Stage III, 2L Nivo, Pembro & Atezo for Advanced Disease

FEATURING Wolfgang Kostler
  • 110 views
  • March 24, 2021
18:57

CECOG Academy

1L Immune CPIs Efficacy Review for Advanced NSCLC: Single Agent IO, IO + Chemo, IO + IO, IO + IO + Chemo

FEATURING Wolfgang Kostler
  • 92 views
  • March 24, 2021
  • 1
19:19

CECOG Academy

Skeletal Health in Lung Cancer: Prevalence of Bone Mets, Prevalence and Significance of Skeletal-Related Events, Treatment Options

FEATURING Jelena Spasic
  • 116 views
  • March 24, 2021
28:04

CECOG Academy

Immune CPIs as Mono and Combination Therapy for RCC: New 1L Strategies + ESMO Updated Guidelines, Clinical & Biological Drivers for Treatment Decisions

FEATURING Manuela Schmidinger
  • 223 views
  • March 22, 2021
  • 1
25:07

CECOG Academy

Skeletal Health in Prostate Cancer: What Is the Impact of Long-Term ADT on Bone Health and How Can We Avoid It?

FEATURING Daniele Santini
  • 29 views
  • March 22, 2021